Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 study

0 avis

Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 study

Archive ouverte

Edité par CCSD ; Medknow Publications -

International audience. Few data have been published on the management of patients with synchronous head-and-neck cancer (HNC) and lung cancer (LC). This observational study was undertaken to describe the management of these patients in multiple centers.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis

Archive ouverte | Monnet, Isabelle | CCSD

International audience. Background: The role and timing of whole or stereotaxic brain radiotherapy (BR) in patients with advanced non-small cell lung cancer (aNSCLC) and asymptomatic brain metastases (aBMs) are not ...

Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer

Archive ouverte | Bylicki, Olivier | CCSD

International audience

Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine–atezolizumab combination for stage-IV non-small-cell lung cancer – VinMetAtezo trial, (GFPC^‡ 04-2017)

Archive ouverte | Vergnenegre, Alain | CCSD

International audience. Metronomic chemotherapy is defined as frequent low-dose administration without prolonged drug-free breaks. Combining immune-checkpoint inhibitors and metronomic chemotherapy is a new approach...

Chargement des enrichissements...

Syracuse